HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CF PHARMTECH

9.600

+0.3153.39%

Volume:3.54M

Turnover:33.29M

Market Cap:4.15B

PE:1.45K

High:9.800

Open:9.285

Low:8.880

Close:9.285

52wk High:48.800

52wk Low:8.880

Shares:432.00M

HK Float Shares:323.00M

Volume Ratio:1.28

T/O Rate:1.09%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.007

ROE:0.21%

ROA:-0.83%

PB:2.65

PE(LYR):1,454.55

PS:8.13

Loading ...

Overview Company News Filings

CF Pharmtech (02652) Secures 2026 Technology Innovation Golden Bull Award, Pushing Boundaries in Inhalation Therapies to Shape the Future of Respiratory Care

CF PharmTech (SEHK:2652) Stock Pressured By Widening Losses And Thin Profit Clarity

Simply Wall St.

CF Pharmtech Reports Interim Revenue of RMB 210 Million, Up 2.1% Year-on-Year

CF PharmTech FY26 H1 Net Loss Widens to RMB 10.51 Million; Revenue Rises 2.08% to RMB 210.15 Million

CF Pharmtech Wraps Up Issuance of 21.75 Million New H-Shares

CF PharmTech Releases Revised Articles of Association: Capital Structure, Governance Framework and Dividend Rules Clarified

Bulletin Express

CF PharmTech Files HKEX Next-Day Disclosure Return, Lifts Share Capital with 21,747,700 New H Shares at HKD 13.82 Each

Hong Kong Stock Alert | CF PHARMTECH (02652) Surges Over 20% Intraday on Two New Clinical Approvals for ICF001, Highlighting Long-Acting Inhaled Prodrug Design Edge

Hong Kong Stock Movers | CF PHARMTECH (02652) Surges Over 5% as ICF001 Covers Four Major Indications Including IPF and PPF, with Plans to Launch Phase I Trials Domestically and Overseas

CF PHARMTECH Secures Two Additional Clinical Approvals for ICF001, Expanding Coverage Across Four Major Indications

CF PHARMTECH (02652) Secures Expanded Clinical Trial Approval for ICF001 Across Additional Indications

CF Pharmtech, - Receives Nmpa Implied Clinical Trial Approvals for Icf001 in Ipf and Ppf

THOMSON REUTERS

CF PharmTech Says NMPA Clears Icf001 Trials in IPF, PPF

CF PharmTech Sets 31 August 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend

Bulletin Express

CF PharmTech Schedules Board Meeting to Review Interim Results

CF Pharmtech Hits 10-Month Low, Raised HKD 295 Million in Quick Placement Amid R&D Spending and Valuation Correction

Hong Kong Stocks Midday Summary: Hang Seng Index Edges Up 0.07% as Healthcare Sector Leads Gains

CF Pharmtech Rises Over 5% at Midday After Completing Placement of 21.7 Million New H Shares

CF PHARMTECH Shares Surge Over 5% Following Completion of H-Share Placement, ICF001 Poised to Fill Clinical Gap in PH-ILD Treatment

CF PharmTech Completes Placement of 21,747,700 New H Shares at HK$ 13.82 Each

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/02652/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02652","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"CF PHARMTECH","latestPrice":9.6,"timestamp":1789027724005,"preClose":9.285,"halted":0,"volume":3535000,"delay":0,"changeRate":0.0339256865912762,"floatShares":323000000,"shares":432000000,"eps":0.0066,"marketStatus":"Not Yet Opened","change":0.315,"latestTime":"09-10 16:08:44","open":9.285,"high":9.8,"low":8.88,"amount":33290074,"amplitude":0.099085,"askPrice":9.625,"askSize":14000,"bidPrice":9.6,"bidSize":4400,"shortable":3,"etf":0,"ttmEps":-0.018,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":9.285,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":1.283914,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","floatShares":323000000,"roa":"-0.83%","roe":"0.21%","lyrEps":0.0066,"volumeRatio":1.283914,"shares":432000000,"dividePrice":0,"high":9.8,"amplitude":0.099085,"preClose":9.285,"low":8.88,"week52Low":8.88,"pbRate":"2.65","psRate":"8.13","week52High":48.8,"institutionHeld":0,"latestPrice":9.6,"committee":-0.521739,"eps":0.0066,"divideRate":0,"volume":3535000,"delay":0,"ttmEps":-0.018,"open":9.285,"prevYearClose":35,"prevWeekClose":11,"prevMonthClose":14.09,"prevQuarterClose":21,"fiveDayClose":11.8,"twentyDayClose":17.52,"sixtyDayClose":17.91},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02652\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null},{"date":"2026-03-30","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02652\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02652\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02652\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02652","date":"2026-09-09","current":-533.333333,"percent":0.026667,"low":-715.224392,"twenty":411.638127,"median":490.083342,"eighty":2811.882705,"high":3595.964728,"avg":1426.910593,"sd":1217.73066,"marketCap":3773074763},"quantilePoints":[{"date":"2025-10-10","current":420.512992,"twenty":-8.053739,"median":420.512992,"eighty":438.465035,"marketCap":12738371726},{"date":"2025-10-17","current":400.969089,"twenty":380.917252,"median":393.18793,"eighty":412.695431,"marketCap":12136883281},{"date":"2025-10-24","current":382.04749,"twenty":383.954109,"median":395.798507,"eighty":407.879105,"marketCap":11568353106},{"date":"2025-10-31","current":411.638127,"twenty":385.87135,"median":395.798507,"eighty":410.009732,"marketCap":12482945126},{"date":"2025-11-07","current":380.629431,"twenty":385.87135,"median":397.412529,"eighty":410.009732,"marketCap":11535394836},{"date":"2025-11-14","current":413.442652,"twenty":386.82146,"median":399.24986,"eighty":411.625005,"marketCap":12565340803},{"date":"2025-11-21","current":474.663516,"twenty":387.596392,"median":401.654037,"eighty":419.1227,"marketCap":14419243545},{"date":"2025-11-28","current":513.213561,"twenty":390.697015,"median":408.734506,"eighty":451.19497,"marketCap":15646939138},{"date":"2025-12-05","current":509.365027,"twenty":391.797785,"median":411.605323,"eighty":487.699676,"marketCap":15556303893},{"date":"2025-12-12","current":478.26383,"twenty":394.588712,"median":413.442652,"eighty":485.541496,"marketCap":14633472306},{"date":"2025-12-19","current":468.273561,"twenty":396.041553,"median":429.606948,"eighty":482.974301,"marketCap":14361566570},{"date":"2025-12-24","current":469.497744,"twenty":396.770692,"median":439.211078,"eighty":482.563912,"marketCap":14443962248},{"date":"2026-01-02","current":452.984556,"twenty":397.492287,"median":451.385447,"eighty":481.570975,"marketCap":13990786022},{"date":"2026-01-09","current":417.797013,"twenty":398.674444,"median":438.955991,"eighty":480.057858,"marketCap":12936121351},{"date":"2026-01-16","current":442.060347,"twenty":399.985866,"median":432.778937,"eighty":478.730146,"marketCap":13731858722},{"date":"2026-01-23","current":466.639698,"twenty":400.772068,"median":439.902936,"eighty":477.371374,"marketCap":14481468286},{"date":"2026-01-30","current":480.840623,"twenty":401.791027,"median":446.916666,"eighty":477.757159,"marketCap":14990389486},{"date":"2026-02-06","current":464.022312,"twenty":403.190746,"median":452.185001,"eighty":477.033593,"marketCap":14502764350},{"date":"2026-02-13","current":452.173894,"twenty":406.744138,"median":454.320794,"eighty":475.6532,"marketCap":14213623359},{"date":"2026-02-20","current":472.094804,"twenty":408.734506,"median":454.916554,"eighty":476.776403,"marketCap":14818441932},{"date":"2026-02-27","current":505.751529,"twenty":411.273773,"median":459.838493,"eighty":479.42962,"marketCap":16048983093},{"date":"2026-03-06","current":445.246344,"twenty":411.572519,"median":460.887466,"eighty":481.94993,"marketCap":14015073071},{"date":"2026-03-13","current":299.287031,"twenty":402.338985,"median":457.528006,"eighty":481.000215,"marketCap":9464083401},{"date":"2026-03-20","current":315.053976,"twenty":397.81132,"median":454.320794,"eighty":480.840623,"marketCap":9924943114},{"date":"2026-03-27","current":299.095644,"twenty":391.175665,"median":451.779671,"eighty":479.42962,"marketCap":9398246299},{"date":"2026-04-02","current":3318.248683,"twenty":389.832113,"median":451.779671,"eighty":480.872541,"marketCap":9381570423},{"date":"2026-04-10","current":3321.445916,"twenty":390.816678,"median":452.984556,"eighty":482.236241,"marketCap":9463036901},{"date":"2026-04-17","current":3317.060015,"twenty":392.419904,"median":455.282385,"eighty":483.410603,"marketCap":9454509433},{"date":"2026-04-24","current":2996.4431,"twenty":394.891161,"median":460.26919,"eighty":490.336167,"marketCap":8541149514},{"date":"2026-04-30","current":3202.871531,"twenty":396.041553,"median":462.144769,"eighty":499.979081,"marketCap":9131900891},{"date":"2026-05-08","current":3148.404437,"twenty":397.173254,"median":463.774025,"eighty":508.169798,"marketCap":9007763175},{"date":"2026-05-15","current":2973.181714,"twenty":398.099028,"median":464.50673,"eighty":512.854422,"marketCap":8528814526},{"date":"2026-05-22","current":2811.882705,"twenty":399.495195,"median":466.720409,"eighty":2921.871357,"marketCap":8047680823},{"date":"2026-05-29","current":3180.044455,"twenty":400.476536,"median":467.247998,"eighty":2926.706614,"marketCap":9133017429},{"date":"2026-06-05","current":2895.334441,"twenty":400.969089,"median":468.273561,"eighty":2926.706614,"marketCap":8327404730},{"date":"2026-06-12","current":2591.262092,"twenty":402.338985,"median":469.314298,"eighty":2919.612019,"marketCap":7447807192},{"date":"2026-06-18","current":2679.987141,"twenty":403.474666,"median":471.144686,"eighty":2910.923271,"marketCap":7719084937},{"date":"2026-06-26","current":2653.65777,"twenty":407.739322,"median":472.774581,"eighty":2903.774482,"marketCap":7608107678},{"date":"2026-07-03","current":2674.595079,"twenty":410.258066,"median":474.904398,"eighty":2905.018632,"marketCap":7673871980},{"date":"2026-07-10","current":2510.065653,"twenty":411.453021,"median":477.841604,"eighty":2898.212797,"marketCap":7192970522},{"date":"2026-07-17","current":2212.458756,"twenty":411.611884,"median":479.42962,"eighty":2892.703479,"marketCap":6362696210},{"date":"2026-07-24","current":2249.530522,"twenty":411.787912,"median":481.475073,"eighty":2888.435745,"marketCap":6470762659},{"date":"2026-07-31","current":2830.800739,"twenty":412.509722,"median":482.52515,"eighty":2884.270453,"marketCap":8158252159},{"date":"2026-08-07","current":2582.169982,"twenty":413.490204,"median":483.399827,"eighty":2872.355071,"marketCap":7456157987},{"date":"2026-08-14","current":2399.972298,"twenty":415.255724,"median":487.118208,"eighty":2848.370255,"marketCap":6938825440},{"date":"2026-08-21","current":2153.795127,"twenty":418.883405,"median":491.347467,"eighty":2826.107192,"marketCap":6240837082},{"date":"2026-08-28","current":2055.558094,"twenty":420.751477,"median":499.411825,"eighty":2817.123583,"marketCap":5957535925},{"date":"2026-09-04","current":-569.998069,"twenty":413.490204,"median":496.308733,"eighty":2813.278273,"marketCap":4516395257},{"date":"2026-09-09","current":-475.425331,"twenty":411.638127,"median":490.083342,"eighty":2811.882705,"marketCap":3773074763}],"updateTime":1789043248765},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02652\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1172001994","title":"CF Pharmtech (02652) Secures 2026 Technology Innovation Golden Bull Award, Pushing Boundaries in Inhalation Therapies to Shape the Future of Respiratory Care","url":"https://stock-news.laohu8.com/highlight/detail?id=1172001994","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172001994?lang=en_us&edition=fundamental","pubTime":"2026-09-07 11:06","pubTimestamp":1788750387,"startTime":"0","endTime":"0","summary":"On September 6, 2026, the \"2026 Xiamen Sci-Tech Innovation and Securities Industry Development Conference暨Securities Industry Golden Bull Award Ceremony,\" hosted by China Securities Journal, took...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664631108","title":"CF PharmTech (SEHK:2652) Stock Pressured By Widening Losses And Thin Profit Clarity","url":"https://stock-news.laohu8.com/highlight/detail?id=2664631108","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664631108?lang=en_us&edition=fundamental","pubTime":"2026-09-01 23:32","pubTimestamp":1788276756,"startTime":"0","endTime":"0","summary":"CF PharmTech stock has already been under pressure, with the share price down about 31% over the past three months, and today’s earnings give investors a clear reason why. The market is reacting to a story that is not about revenue size; it is about profits that have slipped into a loss again.\nThe headline for this half is simple. CF PharmTech generated revenue of C¥210.154 million but reported a net loss of C¥10.506 million and a loss per share. That profit squeeze lands on a stock already...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2652/cf-pharmtech-shares/news/cf-pharmtech-sehk2652-stock-pressured-by-widening-losses-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2652/cf-pharmtech-shares/news/cf-pharmtech-sehk2652-stock-pressured-by-widening-losses-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111083124","title":"CF Pharmtech Reports Interim Revenue of RMB 210 Million, Up 2.1% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1111083124","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111083124?lang=en_us&edition=fundamental","pubTime":"2026-08-31 22:07","pubTimestamp":1788185267,"startTime":"0","endTime":"0","summary":"CF Pharmtech (02652) has released its interim results for 2026, posting revenue of RMB 210 million, a 2.1% increase compared to the same period last year. This growth was primarily driven by...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663165006","title":"CF PharmTech FY26 H1 Net Loss Widens to RMB 10.51 Million; Revenue Rises 2.08% to RMB 210.15 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663165006","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663165006?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:36","pubTimestamp":1788183360,"startTime":"0","endTime":"0","summary":"CF PharmTech FY26 H1 net loss widens to RMB 10.51 million; revenue rises 2.08% to RMB 210.15 millionCF PharmTech posted a net loss of RMB 10.51 million, worsening from RMB 1.23 million a year earlier.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL98lX14:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190191183","title":"CF Pharmtech Wraps Up Issuance of 21.75 Million New H-Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1190191183","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190191183?lang=en_us&edition=fundamental","pubTime":"2026-08-28 23:46","pubTimestamp":1787931980,"startTime":"0","endTime":"0","summary":"CF Pharmtech (02652) has announced the completion of a share issuance, marking a significant step in its capital management strategy.According to the company's latest disclosure, on 6 August 2026, CF...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138766694","title":"CF PharmTech Releases Revised Articles of Association: Capital Structure, Governance Framework and Dividend Rules Clarified","url":"https://stock-news.laohu8.com/highlight/detail?id=1138766694","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138766694?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:23","pubTimestamp":1787927004,"startTime":"0","endTime":"0","summary":"CF PharmTech (CF PharmTech, 02652) has published its updated Articles of Association, effective 6 August 2026, detailing the company’s capital structure, shareholder rights and corporate-governance...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662099896","title":"CF PharmTech Files HKEX Next-Day Disclosure Return, Lifts Share Capital with 21,747,700 New H Shares at HKD 13.82 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2662099896","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662099896?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:06","pubTimestamp":1787925970,"startTime":"0","endTime":"0","summary":"CF PharmTech files HKEX next-day disclosure return, lifts share capital with 21,747,700 new H shares at HKD 13.82 eachCF Pharmtech filed a next day disclosure return covering an issuance of 21,747,700","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL9qNHrD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195250789","title":"Hong Kong Stock Alert | CF PHARMTECH (02652) Surges Over 20% Intraday on Two New Clinical Approvals for ICF001, Highlighting Long-Acting Inhaled Prodrug Design Edge","url":"https://stock-news.laohu8.com/highlight/detail?id=1195250789","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195250789?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:14","pubTimestamp":1787796855,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) shares climbed more than 20% during intraday trading, last up 6.14% at HK$16.2 with turnover reaching HK$58.31 million.The company recently announced that its self-developed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","KCAI","VXUS","BK4588","02652","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132112506","title":"Hong Kong Stock Movers | CF PHARMTECH (02652) Surges Over 5% as ICF001 Covers Four Major Indications Including IPF and PPF, with Plans to Launch Phase I Trials Domestically and Overseas","url":"https://stock-news.laohu8.com/highlight/detail?id=1132112506","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132112506?lang=en_us&edition=fundamental","pubTime":"2026-08-25 09:51","pubTimestamp":1787622692,"startTime":"0","endTime":"0","summary":"Shares of CF PHARMTECH (02652) climbed more than 5% in Hong Kong trading, last up 5.46% at HK$16.06 with turnover reaching HK$6.502 million. The company announced that its self-developed long-acting...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191","BK4588","VXUS","KCAI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104287705","title":"CF PHARMTECH Secures Two Additional Clinical Approvals for ICF001, Expanding Coverage Across Four Major Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=1104287705","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104287705?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:00","pubTimestamp":1787576431,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that its self-developed long-acting inhaled dry powder candidate drug, ICF001, has received implied approval from the National Medical Products Administration to...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144024774","title":"CF PHARMTECH (02652) Secures Expanded Clinical Trial Approval for ICF001 Across Additional Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=1144024774","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144024774?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:41","pubTimestamp":1787571660,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that its independently developed long-acting inhaled dry powder candidate drug, ICF001, has received implied clinical trial approval from the National Medical...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BMED","PSYK","IBBJ","02652","IBBQ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661579275","title":"CF Pharmtech, - Receives Nmpa Implied Clinical Trial Approvals for Icf001 in Ipf and Ppf","url":"https://stock-news.laohu8.com/highlight/detail?id=2661579275","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661579275?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:36","pubTimestamp":1787571383,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L068:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275570","title":"CF PharmTech Says NMPA Clears Icf001 Trials in IPF, PPF","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275570","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275570?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:36","pubTimestamp":1787571383,"startTime":"0","endTime":"0","summary":"CF PharmTech says NMPA clears ICF001 trials in IPF, PPFCF PharmTech received NMPA implied clinical trial clearances for ICF001 in idiopathic pulmonary fibrosis, plus progressive pulmonary fibrosis.The","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL13HdT2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162951635","title":"CF PharmTech Sets 31 August 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1162951635","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162951635?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:49","pubTimestamp":1787129352,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. has announced that its board of directors will convene on 31 August 2026 to deliberate several key agenda items, chief among them the approval and publication of the unaudited...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660244514","title":"CF PharmTech Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660244514","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660244514?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:41","pubTimestamp":1787128864,"startTime":"0","endTime":"0","summary":"CF PharmTech schedules board meeting to review interim resultsCF PharmTech will hold a board meeting on Aug. 31, 2026 to review unaudited interim results for the six months ended June 30, 2026.The boa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL9GD66C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138502813","title":"CF Pharmtech Hits 10-Month Low, Raised HKD 295 Million in Quick Placement Amid R&D Spending and Valuation Correction","url":"https://stock-news.laohu8.com/highlight/detail?id=1138502813","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138502813?lang=en_us&edition=fundamental","pubTime":"2026-08-13 13:11","pubTimestamp":1786597864,"startTime":"0","endTime":"0","summary":"Just ten months after its Hong Kong listing, CF Pharmtech (02652.HK) announced on August 6, 2026, the completion of a rapid placement, issuing 21.7477 million new H-shares at HKD 13.82 per share,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","IPOS","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138513388","title":"Hong Kong Stocks Midday Summary: Hang Seng Index Edges Up 0.07% as Healthcare Sector Leads Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1138513388","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138513388?lang=en_us&edition=fundamental","pubTime":"2026-08-13 12:07","pubTimestamp":1786594067,"startTime":"0","endTime":"0","summary":"The Hang Seng Index nudged up 0.07%, adding 17 points to reach 25,457, while the Hang Seng Tech Index rose 0.30%. Total turnover in the Hong Kong morning session reached 132 billion Hong Kong...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03296","82800","07300","LU1808992512.USD","SG9999004311.SGD","LU0702159343.USD","001093","LU0634319403.HKD","LU0149534421.HKD","LU1282649810.SGD","SG9999000459.SGD","01126","LU2065171402.SGD","LU0417516738.SGD","HSI","LU0251143458.SGD","BK1568","BK1500","BK1577","HSTECH","BK0028","03419","LU0417516902.SGD","SG9999011746.SGD","HSImain","07200","LU1813983027.USD","LU0348783233.USD","LU0593848301.USD","00100","03037","LU1235294995.USD","BK1213","08279","BK1592","02652","SG9999001903.USD","BK1170","LU0384037296.USD","BK1501","IE0008369823.USD","03115","ASMVY","LU0648948544.HKD","SG9999004303.SGD","02513","02800","LU0823040885.USD","02833","300408","LU0211977185.USD","LU0417516571.SGD","601600","BK1509","MCHS","SGXZ23171101.USD","LU0607220059.USD","SG9999000475.SGD","LU2039709279.SGD","83115","LU0540923850.HKD","LU0702159699.USD","LU2065169927.USD","603296","LU0572940350.SGD","LU0572939691.SGD","LU0314109678.HKD","BK1253","BK1169","LU1880383366.USD","BK1117","LU0011963245.USD","MCHmain","BK1155","LU0264606111.USD","LU0488056044.USD","09115","07500","LU1823568750.SGD","LU0227179875.USD","BK0222","BK1589","002565","BK1602","LU1166156734.SGD","BK1614","LU0348825331.USD","HHImain","01910","BK1513","BK1175","LU0274383008.USD","LU1328277881.USD","513600","LU1282649141.HKD","06951","BK1193","BK1227","HK0000286598.CNH","BK1144","LU2065170008.USD","001877","007666","LU0348735423.USD","LU1046421795.USD","LU0348784397.USD","01316","LU1282649067.USD","00325","00522","BK1191","LU0348767384.USD","LU0348766576.USD","02600","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117197561","title":"CF Pharmtech Rises Over 5% at Midday After Completing Placement of 21.7 Million New H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1117197561","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117197561?lang=en_us&edition=fundamental","pubTime":"2026-08-13 12:00","pubTimestamp":1786593630,"startTime":"0","endTime":"0","summary":"CF Pharmtech (02652) saw its stock price surge more than 5% by midday, trading at HKD 16.94, up 5.15%, with a turnover of HKD 85.31 million.The company announced that it had completed the placement...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108135641","title":"CF PHARMTECH Shares Surge Over 5% Following Completion of H-Share Placement, ICF001 Poised to Fill Clinical Gap in PH-ILD Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1108135641","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108135641?lang=en_us&edition=fundamental","pubTime":"2026-08-13 11:14","pubTimestamp":1786590857,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) shares experienced a significant uptick, rising more than 5% in trading. As of the latest report, the stock was up 4.84%, trading at HK$16.89, with a transaction volume of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK4580","LU2264538146.SGD","VXUS","LU0320765489.SGD","LU0256863811.USD","KCAI","BK4161","LU0208291251.USD","LU0256863902.USD","LU1988902786.USD","LU0211331839.USD","LU1989772923.USD","BK4588","BK1191","PH","LU1989772840.SGD","LU1064131342.USD","LU0070302665.USD","BK4585","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657552639","title":"CF PharmTech Completes Placement of 21,747,700 New H Shares at HK$ 13.82 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2657552639","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657552639?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:12","pubTimestamp":1786018340,"startTime":"0","endTime":"0","summary":"CF PharmTech completes placement of 21,747,700 new H shares at HK$ 13.82 eachCF PharmTech completed a private placement of 21,747,700 new H shares on Aug. 6, 2026 at HK$ 13.82 each.Gross proceeds HK$ ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDLbF4Ypv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":145,"code":"91000000","status":"200"}]}}